The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion

Spine

Volumn 32, Issue 10, 2007, Pages 1067-1071

  Minamide, Akihito ^a   Yoshida, Munehito ^a   Kawakami, Mamoru ^a   Okada, Motohiro ^a   Enyo, Yoshio ^a   Hashizume, Hiroshi ^a   Boden, Scott D ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Basic fibroblast growth factor; Bone morphogenetic protein; Mesenchymal stem cell; Spinal fusion

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 1; DEXAMETHASONE; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BONE GRAFT; BONE GROWTH; BONE MARROW CELL; CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL RABBIT; GEL; HISTOLOGY; ILIAC CREST; INTERMETHOD COMPARISON; LUMBAR SPINE; MESENCHYMAL STEM CELL; NONHUMAN; PALPATION; PRIORITY JOURNAL; SPINE FUSION; SPINE RADIOGRAPHY; VERTEBRA;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; ILIUM; LUMBAR VERTEBRAE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; POSTOPERATIVE COMPLICATIONS; RABBITS; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34247642243     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000261626.32999.8a     Document Type: Article

References (23)

1. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
2. Boden SD, Martin GJ, Morone MA, et al. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 1999;24:1179-85.
3. Meyer RA, Gruber HE, Howard BA, et al. Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine 1999;24:747-54.
4. Sandhu HS, Kanim LE, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-22.
5. Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001;26:933-9.
6. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;28:429-34.
7. Barnes B, Boden SD, Louis-Ugbo J, et al. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in nonhuman primates. Spine 2005;30:1127-33.
8. Ohgushi H, Dohi Y, Tamai S, et al. Osteogenic differentiation of marrow stromal cells in porous hydroxyapatite ceramics. J Biomed Mater Res 1993;27:1401-7.
9. Ohgushi H, Dohi Y, Katsuda T, et al. In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 1996;32:333-40.
10. Okumura M, Ohgushi H, Dohi Y, et al. Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 1997;37:122-9.
11. Minamide A, Yoshida M, Kawakami M, et al. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 2005;30:1134-8.
12. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: Radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:412-20.
13. Owen M. Marrow stromal stem cells. J Cell Sci Suppl 1988;10:63-76.
14. Caplan AI. Mesenchmal stem cells. J Orthop Res 1993;9:641-50.
15. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblast maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-7.
16. Noshi T, Yoshikawa T, Dohi Y, et al. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs 2001;25:201-8.
17. Rickard DJ, Sullivan TA, Shenker BJ, et al. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994;161:218-28.
18. Kawaguchi H, Kurokawa T, Hanada K, et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 1994;135:774-81.
19. Pitaru S, Kotev-Emeth S, NoffD, et al. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: Enhanced development of mineralized bone-like tissue in culture. J Bone Miner Res 1993;8:919-29.
20. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997;12:1606-14.
21. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science 1983;220:680-6.
22. Iwasaki M, Nakahara H, Nakase T, et al. Bone morphogenetic protein-2 stimulates osteogenesis but does not affect chondrogenesis in osteochondrogenic differentiation of periosteum-derived cells. J Bone Miner Res 1994;9:1195-204.
23. Yasko AW, Lane JM, Fellinfer EJ, et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 1992;74:659-70.